2026
Journal - Research Article
Fang, T., Chan, A., Chew-Harris, J., & Pham, T. (2026). Distinct profiles of mitochondrial bioenergetics and redox balance in left atrial and ventricular myocardium in the healthy rat heart. Experimental Physiology, 111(3), 1058-1068. doi: 10.1113/ep093102
2025
Journal - Research Article
Keys, T., Greer, C., Adamson, P. D., Pickering, J. W., Pilbrow, A. P., Frampton, C., … Troughton, R. W., … Richards, A. M., Pemberton, C. J., & Chew-Harris, J. (2025). Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes. European Heart Journal Open, 5(5), oeaf097. doi: 10.1093/ehjopen/oeaf097
Montecillo, J., Troughton, R. W., Richards, A. M., Pemberton, C. J., & Chew-Harris, J. (2025). Influence of protein glycosylation on the measurement of soluble urokinase plasminogen activator receptor. Journal of Applied Laboratory Medicine, 10(6), 1564-1579. doi: 10.1093/jalm/jfaf147
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J., Kuan, W., Ibrahim, I., Chan, S., Frampton, C., Li, Z., … Troughton, R., … Pemberton, C., & Richards, M. (2025). Comparison of four novel biomarkers alongside NT-proBNP for risk assessment of heart failure or death within 1 year from admission with acute dyspnoea. Heart, Lung & Circulation, 34(Suppl. 4), 280. doi: 10.1016/j.hlc.2025.06.296
2024
Chapter in Book - Research
Montecillo, J., Pirker, T., Pemberton, C., & Chew-Harris, J. (2024). suPAR in cardiovascular disease. In G. S. Makowski (Ed.), Advances in clinical chemistry (Vol. 121). (pp. 89-131). London, UK: Elsevier. doi: 10.1016/bs.acc.2024.04.005
Journal - Research Article
Greer, C. E., Chew-Harris, J., Adamson, P. D., Pemberton, C. J., Pickering, J. W., Pilbrow, A. P., Frampton, C. M., Troughton, R. W., Doughty, R. N., & Richards, A. M. (2024). Convalescent growth differentiation factor-15 and long-term outcomes after an acute coronary syndrome. Journal of Applied Laboratory Medicine, 09(04), 672-683. doi: 10.1093/jalm/jfae032
Chew-Harris, J., Frampton, C., Greer, C., Appleby, S., Pickering, J. W., Kuan, W. S., … Adamson, P. D., Troughton, R., … Richards, A. M., & Pemberton, C. J. (2024). Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness. International Journal of Cardiology, 406, 132071. doi: 10.1016/j.ijcard.2024.132071
Conference Contribution - Published proceedings: Abstract
Pirker, T., Adamson, P., Pemberton, C., Pham, T., & Chew-Harris, J. (2024). Novel preservation of cardiac mitochondrial integrity by suPAR following anoxia-reoxygenation injury. Heart, Lung & Circulation, 33(Suppl. 2), (pp. S69-S70). doi: 10.1016/j.hlc.2024.04.244
Montecillo, J., Troughton, R., Pemberton, C., & Chew-Harris, J. (2024). Removal of glycosylation improves performance of soluble urokinase plasminogen activator receptor (suPAR) levels for acute decompensated heart failure diagnosis. Heart, Lung & Circulation, 33(Suppl. 2), (pp. S58). doi: 10.1016/j.hlc.2024.04.218
Greer, G., Chew-Harris, J., Adamson, P., Pemberton, C., Pickering, J., Pilbrow, A., Troughton, R., Doughty, R., Richards, M., & Frampton, C. (2024). Convalescent GDF-15 and long-term outcomes after acute coronary syndrome. Heart, Lung & Circulation, 33(Suppl. 2), (pp. S74-S75). doi: 10.1016/j.hlc.2024.04.256
2023
Journal - Research Article
Appleby, S., Frampton, C., Holdaway, M., Chew-Harris, J., Liew, O. W., Chong, J. P. C., Lewis, L., Troughton, R., … Richards, A. M., & Pemberton, C. J. (2023). Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea. Frontiers in Cardiovascular Medicine, 10, 1195082. doi: 10.3389/fcvm.2023.1195082
Conference Contribution - Published proceedings: Abstract
Montecillo, J., Pirker, T., Richards, M., Pemberton, C., & Chew-Harris, J. (2023). Protein glycosylation influences soluble urokinase Plasminogen Activator Receptor (suPAR) measurements. Heart, Lung & Circulation, 32(Suppl. 2), P16. doi: 10.1016/j.hlc.2023.04.237
Pirker, T., Keys, T., Pham, T., Montecillo, J., Byers, M., Pemberton, C., Richards, M., & Chew-Harris, J. (2023). Soluble urokinase Plasminogen Activator Receptor (suPAR) promotes cardioprotective intracellular signalling in myocardial ischaemia. Heart, Lung & Circulation, 32(Suppl. 2), O02. doi: 10.1016/j.hlc.2023.04.208
2022
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J., Kuan, W. S., Ibrahim, I., Chan, S. P., Li, Z., Liew, O. W., Appleby, S., Frampton, C., Troughton, R., … Richards, A. M., & Pemberton, C. J. (2022). Comparative performances of soluble urokinase plasminogen activator receptor and Mid-regional proADM to predict composite death and new heart failure rehospitalisation in acutely breathless patients. European Heart Journal, 43(Suppl. 2), (pp. 1087). doi: 10.1093/eurheartj/ehac544.1087
Keys, T., Chew-Harris, J., Pemberton, C., Adamson, P., Troughton, R., Doughty, R., & Richards, A. M. (2022). Soluble urokinase plasminogen activator receptor predicts mortality and adverse cardiovascular outcomes following acute coronary syndrome. Heart, Lung & Circulation, 31(Suppl. 2), (pp. S28-S29). doi: 10.1016/j.hlc.2022.05.020
2021
Conference Contribution - Published proceedings: Abstract
Holdaway, M., Lewis, L., Chew-Harris, J., Richards, M., Pemberton, C., & Appleby, S. (2021). Erythroferrone can diagnose acute decompensated heart failure in patients presenting with breathlessness. Heart, Lung & Circulation, 30(Suppl. 2), (pp. S76). doi: 10.1016/j.hlc.2021.05.044
Chew-Harris, J., Appleby, S., Adamson, P., Troughton, R., Richards, A. M., & Pemberton, C. (2021). Soluble urokinase plasminogen activator receptor (suPAR) predicts 2-year cardiovascular events in patients after acute chest pain. Heart, Lung & Circulation, 30(Suppl. 2), (pp. S85-S86). doi: 10.1016/j.hlc.2021.05.070
Chew-Harris, J., Appleby, S., Adamson, P., Troughton, R., Richards, A. M., & Pemberton, C. (2021). Prognostic performance of soluble urokinase plasminogen activator receptor (suPAR) in predicting mortality in Asian and Western patients with acute breathlessness. Heart, Lung & Circulation, 30(Suppl. 2), (pp. S86). doi: 10.1016/j.hlc.2021.05.070
Chew-Harris, J., Appleby, S., Adamson, P., Troughton, R., Richards, A. M., & Pemberton, C. (2021). Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in patients with acute chest pain. Heart, Lung & Circulation, 30(Suppl. 2), (pp. S86). doi: 10.1016/j.hlc.2021.05.069
2020
Journal - Research Article
Appleby, S., Chew-Harris, J., Troughton, R. W., Richards, A. M., & Pemberton, C. J. (2020). Analytical and biological assessment of circulating human erythroferrone. Clinical Biochemistry, 79, 41-47. doi: 10.1016/j.clinbiochem.2020.02.001
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J., Appleby, S., Troughton, R. W., Richards, A. M., & Pemberton, C. J. (2020). Soluble urokinase plasminogen activator receptor (suPAR) can predict long-term mortality in patients with acute chest pain. European Heart Journal, 41(Suppl. 2), (pp. 1695). doi: 10.1093/ehjci/ehaa946.1695
Chew-Harris, J., Appleby, S., Kuan, W. S., Ibrahim, I., Chan, S. P., Li, Z., … Frampton, C., Troughton, R. W., … Richards, A. M., & Pemberton, C. J. (2020). Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness. European Heart Journal, 41(Suppl. 2), (pp. 1202). doi: 10.1093/ehjci/ehaa946.1202
Chew-Harris, J., Appleby, S., Troughton, R. W., Richards, A. M., & Pemberton, C. J. (2020). Soluble urokinase plasminogen activator receptor (suPAR) predicts 2-year cardiovascular events in patients after acute chest pain. European Heart Journal, 41(Suppl. 2), (pp. 1696). doi: 10.1093/ehjci/ehaa946.1696
2019
Journal - Research Article
Chew-Harris, J., Appleby, S., Richards, A. M., Troughton, R. W., & Pemberton, C. J. (2019). Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals. Clinical Biochemistry, 69, 36-44. doi: 10.1016/j.clinbiochem.2019.05.010
Conference Contribution - Published proceedings: Abstract
Pemberton, C. J., Lee, J. A., Aldous, S., Appleby, S., Chew-Harris, J., Than, M., Troughton, R. W., & Richards, A. M. (2019). The signal peptide of CNP is a novel predictor of MI, MACE and bleeding risk in chest pain patients. European Heart Journal, 40(Suppl. 1), (pp. 2029). doi: 10.1093/eurheartj/ehz745.0283
Chew-Harris, J. S., Appleby, S., Richards, A. M., Troughton, R. W., & Pemberton, C. J. (2019). Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness. European Heart Journal, 40(Suppl. 1), (pp. 1573). doi: 10.1093/eurheartj/ehz748.0939
2018
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J., Appleby, S., Troughton, R., Richards, M., & Pemberton, C. (2018). Soluble urokinase plasminogen activator receptor is a strong prognostic indicator of mortality in acutely breathless patients. Circulation, 138(Suppl. 1), A11125. [Abstract]
Appleby, S., Chew-Harris, J., Troughton, R., Richards, M., & Pemberton, C. (2018). Erythroferrone can diagnose acute decompensated heart failure in patients presenting with breathlessness. Circulation, 138(Suppl. 1), A11094. [Abstract]
Conference Contribution - Poster Presentation (not in published proceedings)
Chew-Harris, J., Appleby, S., Troughton, R., Richards, M., & Pemberton, C. (2018, August). Soluble urokinase plasminogen activator receptor is a strong prognostic indicator of mortality in acutely breathless patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2017
Journal - Research Other
Chew-Harris, J. S. C., Brennan, S. O., Florkowski, C. M., Troughton, R., & George, P. M. (2017). Deciphering a macro-troponin I complex: A case report. Clinical Chemistry & Laboratory Medicine, 55(4), e77-e79. doi: 10.1515/cclm-2016-0490
2016
Awarded Doctoral Degree
Chew-Harris, J. (2016). Biomarkers of kidney function: Validity of estimates in clinical practice (PhD). University of Otago, Dunedin, New Zealand. Retrieved from http://hdl.handle.net/10523/6883
2015
Journal - Research Article
Chin, P. K. L., Chew-Harris, J. S. C., Florkowski, C. M., & Begg, E. J. (2015). The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance. British Journal of Clinical Pharmacology, 79(2), 268-277. doi: 10.1111/bcp.12501
Chew-Harris, J. S. C., Chin, P. K. L., Florkowski, C. M., George, P., & Endre, Z. (2015). Removal of body surface area normalisation improves raw-measured glomerular filtration rate estimation by the Chronic Kidney Disease Epidemiology Collaboration equation and drug dosing in the obese. Internal Medicine Journal, 45(7), 766-773. doi: 10.1111/imj.12791
Chew-Harris, J. S. C., Florkowski, C. M., George, P. M., & Endre, Z. H. (2015). Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients. Asia-Pacific Journal of Clinical Oncology, 11(2), 142-151. doi: 10.1111/ajco.12312
Journal - Research Other
Chew-Harris, J. S. C., Pickering, J. W., George, P. M., Endre, Z. H., & Florkowski, C. M. (2015). Beware the dog that didn't bark: A tale of creatinine in acute kidney injury. Internal Medicine Journal, 45(8), 878-879. doi: 10.1111/imj.12826
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J. S. C., Florkowski, C. M., Elmslie, J. L., Livesey, J. H., Endre, Z. H., & George, P. M. (2015). Lean mass and age are strong determinants of glomerular filtration rate in healthy men. Pathology, 47(Suppl. 1), (pp. S82-S83). doi: 10.1097/01.PAT.0000461558.08084.7f
Chew-Harris, J. S. C., Chin, P. K. L., Florkowski, C. M., George, P. M., & Endre, Z. H. (2015). Accounting for individual body surface area does improve estimation of absolute GFR using the CKD-EPI equation. Pathology, 47(Suppl. 1), (pp. S82). doi: 10.1097/01.PAT.0000461557.00460.df
2014
Journal - Research Article
Chew-Harris, J. S. C., Florkowski, C. M., Elmslie, J. L., Livesey, J., Endre, Z. H., & George, P. M. (2014). Lean mass modulates glomerular filtration rate in males of normal and extreme body composition. Internal Medicine Journal, 44(8), 749-756. doi: 10.1111/imj.12479
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J. S. C., Florkowski, C. M., George, P. M., & Endre, Z. H. (2014). Does cystatin C improve prediction of glomerular filtration rate? Validation in routine use. Pathology, 46(Suppl. 1), (pp. S84-S85). doi: 10.1097/01.PAT.0000443629.15453.e6
2013
Journal - Research Article
Chew-Harris, J. S. C., Florkowski, C. M., George, P. M., Elmslie, J. L., & Endre, Z. H. (2013). The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Annals of Clinical Biochemistry, 50(1), 39-46. doi: 10.1258/acb.2012.011241
2011
Journal - Research Other
Florkowski, C., & Chew-Harris, J. S. C. (2011). Methods of estimating GFR: Different equations including CKD-EPI. Clinical Biochemist Reviews, 32(2), 75-79. [Review].
Conference Contribution - Published proceedings: Abstract
Florkowski, C., Chew-Harris, J. S. C., Endre, Z. H., Elmslie, J., & George, P. M. (2011). Renal function in extremes of body composition is influenced by muscle mass but not fat mass nor dietary protein intake. Clinical Biochemist Reviews, 34(Suppl. 4), (pp. S25). [Abstract]
Florkowski, C., Chew-Harris, J. S. C., Endre, Z. H., Elmslie, J., & George, P. M. (2011). Bodyfat is a significant determinant of cystatin-C and a confounding factor for interpretation of renal function. Clinical Biochemist Reviews, 34(Suppl. 4), (pp. S25). [Abstract]
2010
Conference Contribution - Published proceedings: Abstract
Chew-Harris, J., Saleem, M., Florkowski, C., Sies, C., & George, P. (2010). Estimating GFR in children with cancer. Clinical Biochemist Reviews, 31(Suppl. 4), (pp. S26). [Abstract]
Chew-Harris, J., Saleem, M., Florkowski, C., Sies, C., & George, P. (2010). Estimating GFR: CKD-EPI or MDRD equation? Clinical Biochemist Reviews, 31(Suppl. 4), (pp. S25). [Abstract]
2009
Journal - Research Other
Chew, J. S. C., Saleem, M., Florkowski, C. M., & George, P. M. (2009). Estimating renal function in oncology patients using cystatin C-based equations [Letter]. Clinical Oncology, 21, 425-426. doi: 10.1016/j.clon.2009.01.012
2008
Journal - Research Article
Chew, J. S. C., Saleem, M., Florkowski, C. M., & George, P. M. (2008). Cystatin C: A paradigm of evidence based laboratory medicine. Clinical Biochemist Reviews, 29(2), 47-62.
Conference Contribution - Published proceedings: Abstract
Chew, J. S. C., Saleem, M., Florkowski, C. M., & George, P. M. (2008). Assessment of cystatin C as a renal marker in oncology patients. Clinical Biochemist Reviews, 29(3), (pp. S132). [Abstract]
